These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1600590

  • 1. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.
    Kötting J, Berger MR, Unger C, Eibl H.
    Cancer Chemother Pharmacol; 1992; 30(2):105-12. PubMed ID: 1600590
    [Abstract] [Full Text] [Related]

  • 2. Hexadecylphosphocholine differs from conventional cytostatic agents.
    Berger MR, Betsch B, Gebelein M, Amtmann E, Heyl P, Scherf HR.
    J Cancer Res Clin Oncol; 1993; 119(9):541-8. PubMed ID: 8392075
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas.
    Berger MR, Yanapirut P, Reinhardt M, Klenner T, Scherf HR, Schmeiser HH, Eibl H.
    Prog Exp Tumor Res; 1992; 34():98-115. PubMed ID: 1438807
    [No Abstract] [Full Text] [Related]

  • 4. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P, Berger MR, Unger C, Eibl H.
    Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143
    [No Abstract] [Full Text] [Related]

  • 5. Antineoplastic activity in vitro of free and liposomal alkylphosphocholines.
    Zeisig R, Jungmann S, Arndt D, Schütt A, Nissen E.
    Anticancer Drugs; 1993 Feb; 4(1):57-64. PubMed ID: 8457716
    [Abstract] [Full Text] [Related]

  • 6. Alkyl phosphocholines: toxicity and anticancer properties.
    Muschiol C, Berger MR, Schuler B, Scherf HR, Garzon FT, Zeller WJ, Unger C, Eibl HJ, Schmähl D.
    Lipids; 1987 Nov; 22(11):930-4. PubMed ID: 3444388
    [Abstract] [Full Text] [Related]

  • 7. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
    Yanapirut P, Berger MR, Reinhardt M, Schmähl D.
    Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356
    [Abstract] [Full Text] [Related]

  • 8. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
    Sobottka SB, Berger MR.
    Cancer Chemother Pharmacol; 1992 Jun; 30(5):385-93. PubMed ID: 1505077
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.
    Kaufmann-Kolle P, Drevs J, Berger MR, Kötting J, Marschner N, Unger C, Eibl H.
    Cancer Chemother Pharmacol; 1994 Jun; 34(5):393-8. PubMed ID: 8070005
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).
    Hilgard P, Stekar J, Voegeli R, Engel J, Schumacher W, Eibl H, Unger C, Berger MR.
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1457-61. PubMed ID: 3141197
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of four anti-cancer alkylphosphocholine derivatives in vitro and in vivo.
    Sobottka SB, Berger MR, Eibl H.
    Int J Cancer; 1993 Feb 01; 53(3):418-25. PubMed ID: 8428795
    [Abstract] [Full Text] [Related]

  • 15. The effects of hexadecylphosphocholine (HPC) a mixture of alkylphosphocholines (APC) and different dietary oils on the growth of a human mammary tumor.
    Colombo DT, Tran LK, Reitz RC.
    Proc West Pharmacol Soc; 1993 Feb 01; 36():127-31. PubMed ID: 8378365
    [No Abstract] [Full Text] [Related]

  • 16. Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammary carcinomas.
    Berger MR, Munder PG, Schmähl D, Westphal O.
    Oncology; 1984 Feb 01; 41(2):109-13. PubMed ID: 6538675
    [Abstract] [Full Text] [Related]

  • 17. DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylnitrosourea.
    Fong LY, Jensen DE, Magee PN.
    Carcinogenesis; 1990 Mar 01; 11(3):411-7. PubMed ID: 2311184
    [Abstract] [Full Text] [Related]

  • 18. Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment.
    Marschner N, Kötting J, Eibl H, Unger C.
    Cancer Chemother Pharmacol; 1992 Mar 01; 31(1):18-22. PubMed ID: 1458555
    [Abstract] [Full Text] [Related]

  • 19. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
    Reinhardt M, Heyl P, Amelung F, Berger MR.
    Arzneimittelforschung; 1992 Oct 01; 42(10):1239-42. PubMed ID: 1282010
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic activity of ET-18-OCH3 and hexadecylphosphocholine against mammary tumors in BD-VI rats.
    Scherf HR, Schuler B, Berger MR, Schmähl D.
    Lipids; 1987 Nov 01; 22(11):927-9. PubMed ID: 3444387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.